By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Growth hormone receptor blockers > Pegvisomant
Growth hormone receptor blockers

Pegvisomant

https://themeditary.com/drug/pegvisomant-6468.html
Medically Reviewed by Oluni Odunlami, MD TheMediTary.Com | Reviewed: Aug 14, 2023  Additional Content by TheMediTary.Com

Generic name: pegvisomant [ peg-vih-so-mant ]

Drug class: Growth hormone receptor blockers

Dosage form: subcutaneous powder for injection (10 mg; 15 mg; 20 mg; 25 mg; 30 mg)

Availability: Prescription only

Pregnancy & Lactation: Risk data available

Brand names: Somavert

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

What is Pegvisomant?

Pegvisomant is a man-made protein that is similar to human growth hormone. Pegvisomant binds to the same receptor in the body as growth hormone, and blocks the effects of growth hormone.

Pegvisomant is used to treat acromegaly (a growth disorder caused by too much growth hormone).

Pegvisomant is usually given after other medications, surgery, or radiation have been tried without successful treatment of symptoms.

Pegvisomant may also be used for purposes not listed in this medication guide.

Warnings

Follow all directions on your medicine label and package. Tell each of your healthcare providers about all your medical conditions, allergies, and all medicines you use.

How should I take Pegvisomant

Follow all directions on your prescription label. Your doctor may occasionally change your dose to make sure you get the best results. Do not use this medicine in larger or smaller amounts or for longer than recommended.

Pegvisomant is injected under the skin. You may be shown how to use injections at home. Do not self-inject this medicine if you do not understand how to give the injection and properly dispose of used needles and syringes.

Pegvisomant is a powder medicine that must be mixed with a liquid (diluent) before using it. If you are using the injections at home, be sure you understand how to properly mix and store the medicine.

Do not shake the medication bottle or you may ruin the medicine. Prepare your dose only when you are ready to give an injection. Do not use if the medicine has changed colors or has particles in it. Call your pharmacist for new medicine.

Your care provider will show you the best places on your body to inject pegvisomant. Use a different place each time you give an injection. Do not inject into the same place two times in a row.

Use pegvisomant regularly to get the most benefit. Get your prescription refilled before you run out of medicine completely.

Each single-use vial (bottle) of this medicine is for one use only. Throw away after one use, even if there is still some medicine left in it after injecting your dose.

Use a disposable needle and syringe only once. Follow any state or local laws about throwing away used needles and syringes. Use a puncture-proof "sharps" disposal container (ask your pharmacist where to get one and how to throw it away). Keep this container out of the reach of children and pets.

You will need frequent blood tests to check your liver function.

Store the powder medicine in a refrigerator. Do not freeze.

After mixing pegvisomant powder with a diluent, store at room temperature and use within 6 hours after mixing.

Dosing information

Usual Adult Dose for Acromegaly:

Loading dose: 40 mg subcutaneously once under medical supervision
Initial dose: 10 mg subcutaneously once a day
Maintenance dose: 10 to 30 mg subcutaneously once a day
Maximum dose: 30 mg per day


Comments:
-Assess baseline liver tests of alanine aminotransferase (ALT), aspartate aminotransferase (AST), serum total bilirubin (TBIL), and alkaline phosphatase (ALP) prior to therapy initiation.

Detailed Pegvisomant dosage information
Pegvisomant Dosage information (more detail)

Before Taking

You should not use pegvisomant if you are allergic to it.

To make sure pegvisomant is safe for you, tell your doctor if you have:

  • diabetes (pegvisomant can lower your blood sugar);

  • liver disease;

  • a latex allergy; or

  • a tumor that secretes growth hormone.

This medicine is not expected to harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant.

It is not known whether pegvisomant passes into breast milk or if it could harm a nursing baby. Tell your doctor if you are breast-feeding a baby.

Pegvisomant is not approved for use by anyone younger than 18 years old.

What happens if I miss a dose?

Use the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not use extra medicine to make up the missed dose.

What happens if I overdose?

Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

Overdose symptoms may include feeling very tired.

What should I avoid while using Pegvisomant?

Follow your doctor's instructions about any restrictions on food, beverages, or activity.

Pegvisomant side effects

Get emergency medical help if you have signs of an allergic reaction: hives; wheezing, difficult breathing; feeling like you might pass out; swelling of your face, lips, tongue, or throat.

Pegvisomant may cause serious side effects. Stop using pegvisomant and call your doctor at once if you have:

  • thickening of the skin or a hard lump where you injected the medicine;

  • easy bruising; or

  • liver problems--nausea, upper stomach pain, itching, tired feeling, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes).

Common side effects of pegvisomant may include:

  • pain;

  • fever, chills, body aches, flu symptoms;

  • nausea, diarrhea;

  • abnormal liver function tests; or

  • pain or irritation where the medicine was injected.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

See more: Pegvisomant Side Effects

What other drugs will affect Pegvisomant?

Tell your doctor about all your current medicines and any you start or stop using, especially:

  • insulin or oral diabetes medication; or

  • narcotic medicine such as fentanyl (Abstral, Actiq, Fentora, Duragesic, Lazanda, Onsolis), hydrocodone (Lortab, Vicodin), hydromorphone (Dilaudid), methadone, morphine, oxycodone (OxyContin, Percocet), and many others.

This list is not complete. Other drugs may interact with pegvisomant, including prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible interactions are listed in this medication guide.

More about Pegvisomant (Pegvisomant [ peg-vih-so-mant ])

Dosage information
Pegvisomant Side Effects
During pregnancy
Drug images
Side effects
Breastfeeding Warnings
Drug class: Growth hormone receptor blockers

Related treatment guides

Acromegaly
Share this Article
Contents
Uses Warnings Before Taking Dosage Side effects Interactions
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by